BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.73 CNY | +0.93% |
|
+1.78% | -18.78% |
| 05-06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
| 04-26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
Evolution of the average Target Price on Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
6d880abc3af96e4e3b01193bf.OA05mnMJz6E7514hHhDUvTwvc9de4hKQ2cx2C6ib_E0.ajV13ytknZdiygFLcEm51HRpP48603TgjYYgY5u2sD5wOn_OI2OE5k-GCw~f5c32474dc2801305febf0d5f35c3e33
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
9.024
CNY
Average target price
14.21
CNY
Spread / Average Target
+57.51%
High Price Target
15.02
CNY
Spread / Highest target
+66.39%
Low Price Target
13.41
CNY
Spread / Lowest Target
+48.63%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2315 Stock
- Consensus Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
